FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
-4.94%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$662M
AUM Growth
+$662M
(-8.2%)
Cap. Flow
-$21.6M
Cap. Flow
% of AUM
-3.27%
Top 10 Holdings %
Top 10 Hldgs %
49.89%
Holding
81
New
8
Increased
13
Reduced
33
Closed
10
Top Buys
| 1 |
Insmed
INSM
|
$22.8M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$20.5M |
| 3 |
AMRN
Amarin Corp
AMRN
|
$13.9M |
| 4 |
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
|
$10.7M |
| 5 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$9.63M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$56.2M |
| 2 |
Nektar Therapeutics
NKTR
|
$25.4M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$14.1M |
| 4 |
Viatris
VTRS
|
$11M |
| 5 |
MODN
MODEL N, INC.
MODN
|
$5.79M |
Sector Composition
| 1 | Healthcare | 72.38% |
| 2 | Communication Services | 8.27% |
| 3 | Industrials | 1.62% |
| 4 | Energy | 0.92% |
| 5 | Financials | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVTR
51
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $1.82M | 0.27% |
1,334,512
-3,580
| -0.3% | -$4.87K |
|
|
BLUE
52
DELISTED
bluebird bio
BLUE
| $1.71M | 0.26% |
18,639
-201
| -1% | -$17.8K |
|
53
LeMaitre Vascular
LMAT
$2.14B
| $1.68M | 0.25% |
48,992
-540
| -1% | -$18.5K |
|
54
Health Care Select Sector SPDR Fund
XLV
$33.8B
| $1.64M | 0.25% |
18,241
| – | – |
|
55
Transmedics
TMDX
$3.65B
| $641K | 0.1% |
27,000
| – | – |
|
|
AGN
56
DELISTED
Allergan plc
AGN
| $363K | 0.05% |
2,157
| – | – |
|
57
Merck
MRK
$210B
| $358K | 0.05% |
4,247
| – | – |
|
58
Health Catalyst
HCAT
$228M
| $351K | 0.05% |
+11,100
| New | +$351K |
|
59
AbbVie
ABBV
$374B
| $312K | 0.05% |
4,114
| – | – |
|
60
Sanofi
SNY
$122B
| $308K | 0.05% |
6,650
| – | – |
|
61
Novartis
NVS
$248B
| $307K | 0.05% |
3,535
| – | – |
|
62
Pfizer
PFE
$141B
| $304K | 0.05% |
8,469
| – | – |
|
63
Baxter International
BAX
$12.1B
| $285K | 0.04% |
3,258
| – | – |
|
64
Johnson & Johnson
JNJ
$429B
| $280K | 0.04% |
2,161
| – | – |
|
65
10x Genomics
TXG
$1.66B
| $252K | 0.04% |
+5,000
| New | +$252K |
|
66
Steris
STE
$23.9B
| $238K | 0.04% |
1,649
| – | – |
|
|
HRC
67
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $223K | 0.03% |
2,121
| – | – |
|
68
Smith & Nephew
SNN
$16.2B
| $215K | 0.03% |
+4,472
| New | +$215K |
|
69
Amgen
AMGN
$153B
| $211K | 0.03% |
1,092
| – | – |
|
70
Grifois
GRFS
$6.53B
| $204K | 0.03% |
10,166
| – | – |
|
|
DYNT
71
DELISTED
Dynatronics Corp
DYNT
| $122K | 0.02% |
121,267
+3,648
| +3% | +$3.67K |
|
|
ARRY
72
DELISTED
Array Biopharma Inc
ARRY
| – | – |
-1,212,545
| Closed | -$56.2M |
|
|
AERI
73
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| – | – |
-478,174
| Closed | -$14.1M |
|
74
Thermo Fisher Scientific
TMO
$183B
| – | – |
-797
| Closed | -$234K |
|
|
75
Nektar Therapeutics
NKTR
$543M
| – | – |
-713,769
| Closed | -$25.4M |
|